Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 633Terminated 246Active not recruiting 65Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 12Gastrointestinal 10Thoracic 9Gynecologic 9Lymphoid 6Other hematologic neoplasm 5Genitourinary 5Other 3Myeloid 2Sarcoma 1Plasma cell 1NET 1Head & Neck 1Endocrine 1Dermatologic 1CNS 1

Conditions

Multiple Myeloma 1

Interventions

pomalidomide 1Dexamethasone 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Has results × Plasma cell × Clear all
NCT01754402 2024-02-20

Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma

Duke University

Phase 1/2 Unknown
56 enrolled 12 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡